Prevention is one of the most powerful yet underutilized levers for reducing healthcare costs and improving health outcomes. Today, only about 3% of national health spending is directed toward preventive care despite clear evidence that prevention reduces disease burden, lowers avoidable utilization and strengthens health system performance. As health systems face increasing pressure to take on financial risk, manage increasingly complex populations and deliver measurable outcomes, embedding prevention into care delivery has become an essential strategy for long-term, sustainable success.

Recent policy momentum has created new opportunities to elevate prevention as a driver of value-based success. The Centers for Medicare & Medicaid Services (CMS) is targeting 100% of Medicare beneficiaries to be in accountable care relationships by 2030. At the same time, health systems are expected to demonstrate improvements in outcomes. From vaccinations to chronic disease management, prevention directly supports these goals, helping organizations meet quality metrics, reduce costs and improve patient care and experience.

With global and US policy expertise, faculty offer unique perspectives on how a shifting policy environment and a focus on prevention can support the shift to value-based care. This session will explore these dynamics and provide attendees with timely insights into why prevention matters now more than ever. Participants will learn how prevention fits into emerging models of care, how evolving policy is shaping opportunities and what steps leaders can take to make prevention a priority in their organizations.

The journey toward value-based care models for health systems has not been without its challenges, both financially and operationally. Strategic collaborations across the healthcare ecosystem can be a key part of advancing a value-based care strategy. The Centers for Medicare & Medicaid Services (CMS) recently announced a key milestone towards its stated goal of moving 100% of traditional Medicare beneficiaries into accountable care relationships focused on quality and total cost of care by 2030. As of January 2025, more than half of people with traditional (fee-for-service) Medicare are in an accountable care relationship with a provider. This webinar will provide actionable steps for how healthcare leaders can evaluate, initiate and deliver strategic collaborations, including best practices from a healthcare system and pharma manufacturer joint effort. This session will illustrate how healthcare leaders can work together to assess opportunities and build, implement and measure solutions.

As lifespans are increasing, so too is the burden of chronic disease. Meanwhile, diseases that once largely affected older populations are now afflicting younger people too. Yet only around 3% of total health spending in wealthy countries is dedicated to prevention, meaning people live with diseases that could have been prevented or controlled earlier, and health systems must deal with the consequences. At GSK, we believe that getting ahead of disease is the best investment — for people, healthcare systems and economies.